These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1732708)

  • 1. Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment.
    Xu SX; Monsma FJ; Sibley DR; Creese I
    Life Sci; 1992; 50(5):383-96. PubMed ID: 1732708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studies.
    Creese I; Sibley DR; Xu SX
    Neurochem Int; 1992 Mar; 20 Suppl():45S-48S. PubMed ID: 1365454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat.
    Angulo JA; Coirini H; Ledoux M; Schumacher M
    Brain Res Mol Brain Res; 1991 Sep; 11(2):161-6. PubMed ID: 1661813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum.
    Chen JF; Weiss B
    Brain Res Dev Brain Res; 1991 Nov; 63(1-2):95-104. PubMed ID: 1665109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
    Jung AB; Bennett JP
    Brain Res Dev Brain Res; 1996 Jul; 94(2):109-20. PubMed ID: 8836569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA; Mansour A; Watson SJ
    Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat striatal and mesencephalic neurons contain the long isoform of the D2 dopamine receptor mRNA.
    Le Moine C; Bloch B
    Brain Res Mol Brain Res; 1991 Jul; 10(4):283-9. PubMed ID: 1681404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic regulation of cholecystokinin mRNA content in rat striatum.
    Ding XZ; Mocchetti I
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):77-83. PubMed ID: 1312208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative in situ hybridization evidence for differential regulation of proenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine.
    Cadet JL; Zhu SM; Angulo JA
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):59-67. PubMed ID: 1312206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine.
    Chen JF; Qin ZH; Szele F; Bai G; Weiss B
    Neuropharmacology; 1991 Sep; 30(9):927-41. PubMed ID: 1833662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues.
    Martres MP; Sokoloff P; Giros B; Schwartz JC
    J Neurochem; 1992 Feb; 58(2):673-9. PubMed ID: 1309568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons.
    Pollack AE; Wooten GF
    Brain Res Mol Brain Res; 1992 Mar; 13(1-2):35-41. PubMed ID: 1315917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors.
    Qin ZH; Chen JF; Weiss B
    J Neurochem; 1994 Feb; 62(2):411-20. PubMed ID: 8294904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered striatal function in a mutant mouse lacking D1A dopamine receptors.
    Drago J; Gerfen CR; Lachowicz JE; Steiner H; Hollon TR; Love PE; Ooi GT; Grinberg A; Lee EJ; Huang SP
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12564-8. PubMed ID: 7809078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain.
    Srivastava LK; Morency MA; Bajwa SB; Mishra RK
    J Mol Neurosci; 1990; 2(3):155-61. PubMed ID: 1703431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment.
    Rogue P; Hanauer A; Zwiller J; Malviya AN; Vincendon G
    Eur J Pharmacol; 1991 Jun; 207(2):165-8. PubMed ID: 1679015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment.
    Matsunaga T; Ohara K; Natsukari N; Fujita M
    Neurosci Res; 1991 Nov; 12(3):440-5. PubMed ID: 1664925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR
    Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.